Home » Podcast
Podcast
-
Leaps by Bayer: Agtech investors look for zebras, not unicorns.
Listen nowIf you happen to be a human being, chances are you need to eat in order to survive. Agriculture is as crucial an industry to the maintenance of modern society as any other – and with a growing population and threats from climate change, finding new ways to produce more food is more important than ever. So why is it that investment into innovative agricultural technology has been so weak in recent years relative to other sectors?
-
Argentina’s turbulent economy is a forge for fintech founders
Listen nowInvesting in fintech is hard wherever you are, but what if where you are is known for its economic and political turbulence? My guest today is Sebastian Spena, the managing director of Galicia Ventures, the corporate VC unit of Argentinian financial services company Grupo Galicia.
-
Looking ahead at fintech’s comeback
Listen nowThe past year has been a big one for fintech startups. The high interest rate environment we’ve been under is slowly easing, along with the uncertainties stemming from having to wait for the outcome of the election in the US. The huge amounts of capital that have been parked on the sidelines are now looking to be deployed, and momentum is returning to the fintech space.
-
We are in another iPhone Cambrian explosion for the chips industry
Listen nowFor every dollar that is invested in semiconductors, around $3 of economic activity is thought to be generated downstream – and in this case, downstream means absolutely anything technology-related. Just about piece of tech equipment you can buy today will rely in some way on a semi-conductor.
-
Torq hopes to replicate Brazil’s fintech success across LatAm
Listen nowLatin America has always been fertile ground for fintech innovation and growth. Combining a young, tech-savvy population and a relative under-penetration of financial services you may see in other developed markets, there is plenty of opportunity for startups to feast on.
-
Best Nights VC wants people to meet in real life again
Listen nowNightlife has changed in recent years. It’s not just the macro-effects of the pandemic – with higher costs of living and young people having less disposable income – but their preferences are also evolving.
-
How to get first-of-a-kind cleantech projects off the ground
Listen nowWe’ve got a bit of a different episode again this week – Fernando sits down with GCV’s editor-in-chief Maija Palmer, who asks him some questions about a recent report he wrote for GCV’s Global Energy Council on the topic of getting first-of-a-kind cleantech technologies and projects of the ground.
-
M&A and liquidity making a slower comeback in healthcare, but CVCs are stepping up to the plate
Listen nowAt the beginning of the year, I spoke to Bill Taranto, president of the MSD Global Health Innovation Fund about what he expected over the course of the year in the healthcare space. He had predicted that M&As would make a moderate comeback and more liquidity would be coming into the market from private equity firms, and that we would see a wave of consolidations taking shape as smaller “point solutions” get integrated into larger platforms.
-
While others are cautious in a slower Brazilian market, L4 wants to be greedy
Listen nowThe past year has not been the most active for the Brazilian CVC market. High interest rates, lack of sufficient liquidity, and decreased dealflow, among other things, have all slowed it down relative to past years. But that is not true across the board. Some funds, like, L4 Venture Builder – the single-LP fund backed by Brazil’s main stock exchange, B3 – have been investing a lot since it officially launched early in 2023.
-
How Olympus Innovation Ventures is looking into the human body
Listen nowTo fix things in the human body, you have to see them. This is what Olympus does. The legendary Japanese camera-maker, which in recent years divested its camera business and went full-tilt into medical devices, retains its core strength of optics and doubling down in its application to medicine.